Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :1
molecular pharmacology
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
64
0.753
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :2
high content biology
cell biology
pharmacology
nanoparticles
nanomedicine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
39
28
0.718
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :3
Cancer Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
28
0.848
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :4
Project/Team Lead
Drug Discovery
Cell Biology
Pharmacology
Exscientia
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
20
0.909
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :5
Cancer
Oncology
Biochemistry
Pharmacology
Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
26
18
0.692
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :6
drug discovery
drug safety
toxicology
pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
16
0.640
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :7
motivation
reinforcement learning
neuropharmacology
biostatistics
experimental design
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :8
Clinical research
Lung cancer
Targeted Therapy
Oncology
Methodology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :9
COPD
Asthma
receptor pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
9
0.375
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :10
Pharmacology
biology
clinical trials
information
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
9
8
0.889
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :11
drug discovery
bioinformatics
molecular pharmacology
respiratory diseases
autoimmunity
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :12
Pharmacology
Antibiotics
Bacteria
Microbiology
Mathematical modeling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :13
cardiovascular
diabetes
nephrology
pharmacology
medical research
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
2
2
1.000
* Last 6 Years i10 IndexRankings
Ranking Based On Selection :14
фармакология
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
0
0
0
Sylvie Guichard
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
85
64
0.753
molecular pharmacology
oncology
Al Sabirsh
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
39
28
0.718
high content biology
cell biology
pharmacology
nanoparticles
nanomedicine
Christopher J Morrow
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
33
28
0.848
Erik Müllers
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
22
20
0.909
Project/Team Lead
Drug Discovery
Cell Biology
Pharmacology
Exscientia
Kevin Hudson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
26
18
0.692
Cancer
Oncology
Biochemistry
Pharmacology
Drug Discovery
Jorrit Hornberg
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
25
16
0.640
drug discovery
drug safety
toxicology
pharmacology
Benjamin Phillips
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
18
1.000
motivation
reinforcement learning
neuropharmacology
biostatistics
experimental design
Toon Van Der Gronde
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
18
16
0.889
Clinical research
Lung cancer
Targeted Therapy
Oncology
Methodology
Ian Dainty
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
24
9
0.375
COPD
Asthma
receptor pharmacology
James Root
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
9
8
0.889
Pharmacology
biology
clinical trials
information
Tomas Ottosson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
drug discovery
bioinformatics
molecular pharmacology
respiratory diseases
autoimmunity
Antal Martinecz
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
4
4
1.000
Pharmacology
Antibiotics
Bacteria
Microbiology
Mathematical modeling
Pia Walters-Giummarra
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
2
2
1.000
cardiovascular
diabetes
nephrology
pharmacology
medical research
Aleksandr Loshkarev
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
0
0
0